Sapisochin, Gonzalo
Bruix, Jordi
Article History
First Online: 5 January 2017
Competing interests
: G.S. has received a research grant support from Bayer. J.B. received grant support from Asociación Española Contra el Cáncer (PI044031), Bayer, Instituto de Salud Carlos III (PI14/00962), Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement (2014 SGR 605) and WCR (AICR) 16–0026. J.B. has consulted for Abbvie, Arqule, Bayer, BMS, Boehringer, BTG, Gilead, Ingelheim, Kowa, Novartis, Onxeo, OSI, Roche and Terumo.